Michael L. Wang, M.D Get more information ., Simon Rule, M.D., Peter Martin, M.D., Andre Goy, M.D., Rebecca Auer, M.D., Ph.D., Brad S. Kahl, M.D., Wojciech Jurczak, M.D., Ph.D., Ranjana H. Advani, M.D., Jorge E. Romaguera, M.D., Michael E. Williams, M.D., Jacqueline C. Barrientos, M.D., Ewa Chmielowska, M.D., John Radford, M.D., Stephan Stilgenbauer, M.D., Martin Dreyling, M.D., Wieslaw Wiktor Jedrzejczak, M.D., Peter Johnson, M.D., Stephen E. Spurgeon, M.D., Lei Li, Ph.D., Liang Zhang, M.D., Ph.D., Kate Newberry, Ph.D., Zhishuo Ou, M.D., Nancy Cheng, M.S., Bingliang Fang, Ph.D., Jesse McGreivy, M.D., Fong Clow, Sc.D., Joseph J. Buggy, Ph.D., Betty Y. Chang, Ph.D., Darrin M. Beaupre, M.D., Ph.D., Lori A.
Originally the cancer melts away, but it’s still there. And at some point, it figures out a method to get around this specific drug usually. We have to keep searching for new developments so that when this happens, we can dietary supplement or replace the crizotinib with additional treatments to help keep the malignancy under long-term control, said Camidge. At the very least, Camidge said it is very important for anyone identified as having lung cancer to obtain tumor tested. Many commercially available tests are available but the definitive test that qualifies for entry into the study is conducted in those centers with the trial.